These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26160751)

  • 1. Structural and biophysical analysis of sero-specific immune responses using epitope grafted Dengue ED3 mutants.
    Kulkarni MR; Islam MM; Numoto N; Elahi M; Mahib MR; Ito N; Kuroda Y
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1438-43. PubMed ID: 26160751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the envelope protein domain III of dengue-4 virus.
    Volk DE; Lee YC; Li X; Thiviyanathan V; Gromowski GD; Li L; Lamb AR; Beasley DW; Barrett AD; Gorenstein DG
    Virology; 2007 Jul; 364(1):147-54. PubMed ID: 17395234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational prediction and experimental characterization of a "size switch type repacking" during the evolution of dengue envelope protein domain III (ED3).
    Elahi M; Islam MM; Noguchi K; Yohda M; Toh H; Kuroda Y
    Biochim Biophys Acta; 2014 Mar; 1844(3):585-92. PubMed ID: 24373879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling and experimental assessment of a buried Leu-Ile mutation in dengue envelope domain III.
    Kulkarni MR; Numoto N; Ito N; Kuroda Y
    Biochem Biophys Res Commun; 2016 Feb; 471(1):163-8. PubMed ID: 26826384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution crystal structure of dengue-3 envelope protein domain III suggests possible molecular mechanisms for serospecific antibody recognition.
    Elahi M; Islam MM; Noguchi K; Yohda M; Kuroda Y
    Proteins; 2013 Jun; 81(6):1090-5. PubMed ID: 23239402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.
    Chen S; Yu M; Jiang T; Deng Y; Qin C; Qin E
    DNA Cell Biol; 2007 Jun; 26(6):361-7. PubMed ID: 17570760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.
    Zidane N; Dussart P; Bremand L; Bedouelle H
    BMC Infect Dis; 2013 Jul; 13():302. PubMed ID: 23815496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice.
    Chen W; Kawano H; Men R; Clark D; Lai CJ
    J Virol; 1995 Aug; 69(8):5186-90. PubMed ID: 7609092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.
    Lisova O; Belkadi L; Bedouelle H
    J Mol Recognit; 2014 Apr; 27(4):205-14. PubMed ID: 24591178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design.
    Zidane N; Dussart P; Bremand L; Villani ME; Bedouelle H
    Protein Eng Des Sel; 2013 Jun; 26(6):389-99. PubMed ID: 23479674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Barrett AD
    J Gen Virol; 2010 Sep; 91(Pt 9):2249-53. PubMed ID: 20444995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.
    Bray M; Men R; Lai CJ
    J Virol; 1996 Jun; 70(6):4162-6. PubMed ID: 8648761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones.
    Zeng L; Kurane I; Okamoto Y; Ennis FA; Brinton MA
    J Virol; 1996 May; 70(5):3108-17. PubMed ID: 8627790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Immunogenicity of DENV1-4 ED3s Strongly Differ despite Their Almost Identical Three-Dimensional Structures and High Sequence Similarities.
    Islam MD; Sharmin T; Tipo IH; Saha A; Yesmin S; Roy MG; Brindha S; Kuroda Y; Islam MM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.
    Gromowski GD; Roehrig JT; Diamond MS; Lee JC; Pitcher TJ; Barrett AD
    Virology; 2010 Nov; 407(2):237-46. PubMed ID: 20832836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice.
    Chen HW; Hu HM; Wu SH; Chiang CY; Hsiao YJ; Wu CK; Hsieh CH; Chung HH; Chong P; Leng CH; Pan CH
    PLoS One; 2015; 10(12):e0145717. PubMed ID: 26714037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.